title: Treatment of pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) with weight-based anakinra dosing in a Hepatitis B carrier.
authors.affiliation: Department of Dermatology, Beaumont Hospital, Dublin, Ireland.
authors.forename: Lorraine
authors.initials: L
authors.lastname: Jennings
authors.affiliation: Department of Dermatology, Beaumont Hospital, Dublin, Ireland.
authors.forename: Oonagh
authors.initials: O
authors.lastname: Molloy
authors.affiliation: Department of Dermatology, Beaumont Hospital, Dublin, Ireland.
authors.forename: Catherine
authors.initials: C
authors.lastname: Quinlan
authors.affiliation: Department of Dermatology, Beaumont Hospital, Dublin, Ireland.
authors.forename: Genevieve
authors.initials: G
authors.lastname: Kelly
authors.affiliation: Department of Dermatology, Beaumont Hospital, Dublin, Ireland.
authors.forename: Marina
authors.initials: M
authors.lastname: O'Kane
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy*; D000328:Adult; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D005260:Female; D006512:Hepatitis B Core Antigens; D017497:Hidradenitis Suppurativa / Q000188:drug therapy*; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000008:administration & dosage*; D017511:Pyoderma Gangrenosum / Q000188:drug therapy*; D013577:Syndrome
chemical_list: D018501:Antirheumatic Agents; D006512:Hepatitis B Core Antigens; D053590:Interleukin 1 Receptor Antagonist Protein